CLINICAL EFFICACY AND SAFETY OF SILDENAFIL IN ELDERLY PATIENTS WITH ERECTILE DYSFUNCTION
Authors:
- M. FujisawaMFM. Fujisawa
- K. SawadaKSK. Sawada
- 1 January 2004
- journal article
- clinical trial
- Published by Taylor & Francis in Archives of Andrology
- Vol. 50 (4) , 255-260
Abstract
Erectile dysfunction (ED) is a common medical disorder affecting elderly men. Sildenafil citrate has been shown to be an effective and well-tolerated oral agent for treating ED in the general population of adult men with ED of broad-spectrum etiology. Elderly men are more likely to have concomitant medical problems than the general population of men with ED. In this study, we examined the efficacy and safety of sildenafil administration in elderly patients with ED. Forty-four elderly men with ED (> or = 60 years old) of broad-spectrum etiology were treated with 25 mg or 50 mg doses of sildenafil citrate. Age ranged from 60 to 78 years (65 +/- 4.5; means +/- S.D.). Mean follow-up period was 12.3 +/- 6.5 months, with a range of 1 to 25 months. Primary efficacy assessments were performed using the International Index of Erectile Function 5 (IIEF5) before their first dose of sildenafil and after at least 4 weeks of therapy. Serum testosterone was measured before treatment. The mean IIEF5 among all patients increased from 8.5 +/- 3.9 to 20 +/- 4.2 after sildenafil use (P < 0.0001). In patients younger than 70 years, the IIEF5 score increased from 9.5 +/- 5.0 to 17 +/- 4.3 while in patients 70 years and older, the score increased from 8.2 +/- 3.6 to 21 +/- 3.9, a near normalization. The rate of improvement in younger men was higher than in older men. Serum testosterone before treatment was similar in the two groups. The most commonly experienced adverse events were flushing and dyspepsia, which occurred in 6.8% and 2.3%, respectively. No patients discontinued sildenafil treatment due to adverse events. In conclusion, oral sildenafil is efficacious and well tolerated by elderly men with ED, even among those older than 70 years.Keywords
This publication has 20 references indexed in Scilit:
- EFFICACY, SAFETY AND PATIENT ACCEPTANCE OF SILDENAFIL CITRATE AS TREATMENT FOR ERECTILE DYSFUNCTIONJournal of Urology, 2000
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- COMPARISON OF LONG-TERM OUTCOMES OF PENILE PROSTHESES AND INTRACAVERNOSAL INJECTION THERAPYJournal of Urology, 1998
- Comparative Results of Goal Oriented Therapy for Erectile DysfunctionJournal of Urology, 1997
- Quality of Life Effects of Alprostadil Therapy for Erectile DysfunctionJournal of Urology, 1997
- Treatment of Men with Erectile Dysfunction with Transurethral AlprostadilNew England Journal of Medicine, 1997
- Clinical Guidelines Panel on Erectile Dysfunction: Summary Report on the Treatment of Organic Erectile DysfunctionJournal of Urology, 1996
- Quality of Life in Patients Using Self-Administered Intracavernous Injections of Prostaglandin E1 for Erectile DysfunctionJournal of Urology, 1996
- The Management of Impotence in Diabetic Men by Vacuum Tumescence TherapyDiabetic Medicine, 1991